These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9352599)

  • 1. Characterization of immunodominant peptide determinants of IDDM-associated autoantigens in the NOD mouse.
    Zechel MA; Chaturvedi P; Singh B
    Res Immunol; 1997 Jun; 148(5):338-48. PubMed ID: 9352599
    [No Abstract]   [Full Text] [Related]  

  • 2. Epitope dominance: evidence for reciprocal determinant spreading to glutamic acid decarboxylase in non-obese diabetic mice.
    Zechel MA; Krawetz MD; Singh B
    Immunol Rev; 1998 Aug; 164():111-8. PubMed ID: 9795769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes.
    Trembleau S; Penna G; Gregori S; Magistrelli G; Isacchi A; Adorini L
    J Immunol; 2000 Dec; 165(12):6748-55. PubMed ID: 11120794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-based therapies using ignored determinants of beta cell antigens can more effectively inhibit late-stage autoimmune disease in diabetes-prone mice.
    Olcott AP; Tian J; Walker V; Dang H; Middleton B; Adorini L; Washburn L; Kaufman DL
    J Immunol; 2005 Aug; 175(3):1991-9. PubMed ID: 16034144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GAD, a single autoantigen for diabetes.
    von Boehmer H; Sarukhan A
    Science; 1999 May; 284(5417):1135, 1137. PubMed ID: 10366347
    [No Abstract]   [Full Text] [Related]  

  • 6. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes.
    Kaufman DL; Clare-Salzler M; Tian J; Forsthuber T; Ting GS; Robinson P; Atkinson MA; Sercarz EE; Tobin AJ; Lehmann PV
    Nature; 1993 Nov; 366(6450):69-72. PubMed ID: 7694152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamic acid decarboxylase and other autoantigens in IDDM.
    Nepom GT
    Curr Opin Immunol; 1995 Dec; 7(6):825-30. PubMed ID: 8679127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of effectors and regulators are decisive in the manifestations of type 1 diabetes in nonobese diabetic mice.
    Quinn A; Kumar V; Jensen KP; Sercarz EE
    Curr Dir Autoimmun; 2001; 4():171-92. PubMed ID: 11569402
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent.
    Tisch R; Wang B; Serreze DV
    J Immunol; 1999 Aug; 163(3):1178-87. PubMed ID: 10415012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of MHC class II molecules in susceptibility to type I diabetes: identification of peptide epitopes and characterization of the T cell repertoire.
    Chao CC; Sytwu HK; Chen EL; Toma J; McDevitt HO
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9299-304. PubMed ID: 10430937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of glutamic acid decarboxylase-activated T cells with I-Ag7 tetramers.
    Liu CP; Jiang K; Wu CH; Lee WH; Lin WJ
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14596-601. PubMed ID: 11106373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does GAD have a unique role in triggering IDDM?
    Baekkeskov S; Kanaani J; Jaume JC; Kash S
    J Autoimmun; 2000 Nov; 15(3):279-86. PubMed ID: 11040068
    [No Abstract]   [Full Text] [Related]  

  • 13. Deviation of islet autoreactivity to cryptic epitopes protects NOD mice from diabetes.
    Song A; Winer S; Tsui H; Sampson A; Pasceri P; Ellis J; Elliott JF; Dosch HM
    Eur J Immunol; 2003 Feb; 33(2):546-55. PubMed ID: 12645954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The thymus as a site for evaluating the potency of candidate beta cell autoantigens in NOD mice.
    Gerling IC; Atkinson MA; Leiter EH
    J Autoimmun; 1994 Dec; 7(6):851-8. PubMed ID: 7888041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coxsackie virus and diabetes revisited.
    Jones DB; Armstrong NW
    Nat Med; 1995 Apr; 1(4):284. PubMed ID: 7585050
    [No Abstract]   [Full Text] [Related]  

  • 16. Isolation of nonobese diabetic mouse T-cells that recognize novel autoantigens involved in the early events of diabetes.
    Gelber C; Paborsky L; Singer S; McAteer D; Tisch R; Jolicoeur C; Buelow R; McDevitt H; Fathman CG
    Diabetes; 1994 Jan; 43(1):33-9. PubMed ID: 8262314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of immunogenic epitopes of GAD 65 presented by Ag7 in non-obese diabetic mice.
    Chao CC; McDevitt HO
    Immunogenetics; 1997; 46(1):29-34. PubMed ID: 9148785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice.
    Falcone M; Lee J; Patstone G; Yeung B; Sarvetnick N
    J Immunol; 1998 Aug; 161(3):1163-8. PubMed ID: 9686575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of CD4+ T cell-specific epitopes of islet-specific glucose-6-phosphatase catalytic subunit-related protein: a novel beta cell autoantigen in type 1 diabetes.
    Mukherjee R; Wagar D; Stephens TA; Lee-Chan E; Singh B
    J Immunol; 2005 May; 174(9):5306-15. PubMed ID: 15843527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC class I-restricted determinants on the glutamic acid decarboxylase 65 molecule induce spontaneous CTL activity.
    Quinn A; McInerney MF; Sercarz EE
    J Immunol; 2001 Aug; 167(3):1748-57. PubMed ID: 11466400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.